menu
    • menu

    Company profile for ME Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Me Therapeutics is a biotechnology company dedicated to developing next-generation cell and gene therapies for treating serious diseases. By leveraging advanced scientific research and innovative technologies, we aim to create highly personalized therapeutic solutions that address the root causes of genetic and cellular disorders. Our mission is to transform patient care by delivering breakthrough treatments that offer long-la...
    Me Therapeutics is a biotechnology company dedicated to developing next-generation cell and gene therapies for treating serious diseases. By leveraging advanced scientific research and innovative technologies, we aim to create highly personalized therapeutic solutions that address the root causes of genetic and cellular disorders. Our mission is to transform patient care by delivering breakthrough treatments that offer long-lasting, curative outcomes. At Me Therapeutics, we are committed to pushing the boundaries of science to improve lives and reshape the future of medicine.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ME TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    177 Robson St. Vancouver, BC, Canada, V6B 0N3
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.metherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ME Therapeutics Licenses CD22 Nanobody For In Vivo CAR Cell
    ME Therapeutics Licenses CD22 Nanobody For In Vivo CAR Cell

    16 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-16/me-therapeutics-granted-licence-for-cd22-nanobody-asset-to-expand-next-gen-in-vivo-car-cell-therapy

    PHARMIWEB
    16 Oct 2025
    Share Share
    ME Therapeutics Added To CSE25 Index
    ME Therapeutics Added To CSE25 Index

    10 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-10/me-therapeutics-added-to-cse25-index

    PHARMIWEB
    10 Oct 2025
    Share Share
    ME Therapeutics Secures US Patent, Advances Lead Programs
    ME Therapeutics Secures US Patent, Advances Lead Programs

    26 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250926071481/en/ME-Therapeutics-Secures-U.S.-Patent-for-Lead-Candidate-and-Advances-Broader-Therapeutic-Programs

    BUSINESSWIRE
    26 Sep 2025
    Share Share
    ME Therapeutics gets Backing for mRNA cancer, inflammatory Diseases
    ME Therapeutics gets Backing for mRNA cancer, inflammatory Diseases

    21 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250520113649/en/ME-Therapeutics-Receives-Support-to-Advance-mRNA-Therapeutic-Candidates-for-Cancer-and-Inflammatory-Disease

    BUSINESSWIRE
    21 May 2025
    Share Share
    Azome Therapeutics Partners with NCATS to Research Inflammation
    Azome Therapeutics Partners with NCATS to Research Inflammation

    13 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azome-therapeutics-enters-into-crada-with-national-center-for-advancing-translational-sciences-to-investigate-novel-inflammasome-antagonist-to-prevent-bronchopulmonary-dysplasia-302303923.html

    PR NEWSWIRE
    13 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search